| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2014 | CN102432467B Salvianolic acid A magnesium salt, preparation method and use of the salvianolic acid A magnesium salt, and salvianolic acid A magnesium salt-containing freeze-dried powder injection composition |
| 01/15/2014 | CN102406900B External traditional Chinese preparation for treating hyperplasia of mammary glands |
| 01/15/2014 | CN102406848B Traditional Chinese preparation for treating traumatic headache |
| 01/15/2014 | CN102391204B Chiral 2,4-disubstituted-thaizolidinone compounds and preparation method and application thereof in preparation of anticancer medicaments |
| 01/15/2014 | CN102382064B Quinnazolidone derivative, preparation method for same and application thereof |
| 01/15/2014 | CN102379907B Ganoderma lucidum double vitamin methionine preparation and production method thereof |
| 01/15/2014 | CN102341385B Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/15/2014 | CN102336714B Hydantoin ibuprofen derivative and synthetic method and application thereof |
| 01/15/2014 | CN102329319B Novel crystal form for temozolomide, method for preparing temozolomide and medicinal composition of temozolomide |
| 01/15/2014 | CN102266310B Dihydroergotoxine mesylate sustained-release capsule and preparation method thereof |
| 01/15/2014 | CN102250203B Beta-carboline aminoacid benzyl ester, preparation method and application thereof |
| 01/15/2014 | CN102203067B Hedgehog pathway modulators |
| 01/15/2014 | CN102197030B Rotaxane compound and antitumor agent |
| 01/15/2014 | CN102188382B DSPE-PEG-FA-modified nanometer paclitaxel liposome and preparation method thereof |
| 01/15/2014 | CN102159570B Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide |
| 01/15/2014 | CN102085210B Medicinal composition for treating cerebral infarction |
| 01/15/2014 | CN102083443B Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation |
| 01/15/2014 | CN102078290B Method for preparing carbonate lidocaine injection |
| 01/15/2014 | CN102070614B Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts |
| 01/15/2014 | CN102060903B Ginsenoside Rh2 extractive and preparation method thereof |
| 01/15/2014 | CN101880670B 植物血红蛋白 Plants hemoglobin |
| 01/15/2014 | CN101878217B Agent for prevention and/or treatment of skin diseases |
| 01/15/2014 | CN101869559B Application of gartanin compound in preparing medicaments for treating hyperlipidemia |
| 01/15/2014 | CN101781335B New tenofovir disoproxil fumarate crystal and preparation method thereof |
| 01/15/2014 | CN101723936B Kinase suppressor and pharmaceutical application thereof |
| 01/15/2014 | CN101679263B Fluorinated derivatives of deferiprone |
| 01/15/2014 | CN101668426B Smac mimetic dimers and trimers useful as anti-cancer agents |
| 01/15/2014 | CN101557828B Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 01/15/2014 | CN101547903B 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl)]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate |
| 01/15/2014 | CN101524349B Phospholipids compound of bicyclo-ethanol and preparation method thereof |
| 01/15/2014 | CN101506188B Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity |
| 01/14/2014 | USRE44704 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 01/14/2014 | US8629285 Imidazole compounds that modulate HSP90 activity |
| 01/14/2014 | US8629278 Thioacetate compounds, compositions and methods of use |
| 01/14/2014 | US8629276 Inhibitors of human immunodeficiency virus replication |
| 01/14/2014 | US8629274 Hepatitis B antiviral agents |
| 01/14/2014 | US8629273 Diazinylpyrazolyl compounds |
| 01/14/2014 | US8629272 Tricyclic pyrimidine derivatives as wnt antagonists |
| 01/14/2014 | US8629270 Tetrahydropyrrolothiazine compounds |
| 01/14/2014 | US8629185 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof |
| 01/14/2014 | US8629184 Topical formulations for treatment of neuropathy |
| 01/14/2014 | US8629183 Methods for decreasing cartilage damage in dogs |
| 01/14/2014 | US8629182 Method for decreasing cartilage damage in dogs |
| 01/14/2014 | US8629181 Biologically active oils |
| 01/14/2014 | US8629179 Methods and devices for providing prolonged drug therapy |
| 01/14/2014 | US8629178 Sodium tanshinone IIA sulfonate hydrate and preparation method and use thereof |
| 01/14/2014 | US8629177 Nanoencapsulated delta-9-tetrahydrocannabinol |
| 01/14/2014 | US8629176 β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activators |
| 01/14/2014 | US8629175 Functional food additives |
| 01/14/2014 | US8629174 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases |
| 01/14/2014 | US8629173 Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
| 01/14/2014 | US8629172 Methods and compositions for treating post-operative pain comprising clonidine |
| 01/14/2014 | US8629171 Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt |
| 01/14/2014 | US8629170 Anti-viral drugs for treatment of arenavirus infection |
| 01/14/2014 | US8629169 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists |
| 01/14/2014 | US8629168 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors |
| 01/14/2014 | US8629167 Selective androgen receptor modulators |
| 01/14/2014 | US8629166 5-cycloalkyl- or 5-heterocyclyl-nicotinamides |
| 01/14/2014 | US8629165 Methods for treating cognitive disorders |
| 01/14/2014 | US8629164 Inhibitors of NF-κB |
| 01/14/2014 | US8629163 Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors |
| 01/14/2014 | US8629162 Modulators of ATP-binding cassette transporters |
| 01/14/2014 | US8629161 Preventive or remedy for glaucoma |
| 01/14/2014 | US8629160 Alkaloid aminoester derivatives and medicinal composition thereof |
| 01/14/2014 | US8629159 Thiazolidinedione analogues |
| 01/14/2014 | US8629158 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
| 01/14/2014 | US8629157 Pyrrolidine compounds which modulate the CB2 receptor |
| 01/14/2014 | US8629156 Tryptophan hydroxylase inhibitors |
| 01/14/2014 | US8629154 Substituted cycloalcano[e and d] pyrazolo [1,5-a]pyrimidines/antagonists of serotonin 5-HT6 receptors and methods for production and the use thereof |
| 01/14/2014 | US8629153 Use of quinazoline derivatives for the treatment of viral diseases |
| 01/14/2014 | US8629152 Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid |
| 01/14/2014 | US8629150 Compounds for the treatment of hepatitis C |
| 01/14/2014 | US8629149 Oxopiperazine derivatives for the treatment of pain and epilepsy |
| 01/14/2014 | US8629148 Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 01/14/2014 | US8629147 Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders |
| 01/14/2014 | US8629146 Method for stereoselective synthesis of bicyclic heterocyclic compounds |
| 01/14/2014 | US8629145 Therapeutic agent for spinal canal stenosis |
| 01/14/2014 | US8629144 Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline |
| 01/14/2014 | US8629143 Potassium channel modulators |
| 01/14/2014 | US8629142 Modulators of toll-like receptors |
| 01/14/2014 | US8629141 Spiro-oxindole MDM2 antagonists |
| 01/14/2014 | US8629140 Hypotensive lipid and timolol compositions and methods of using same |
| 01/14/2014 | US8629139 Topical use of Levofloxacin for reducing lung inflammation |
| 01/14/2014 | US8629138 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/14/2014 | US8629137 CGRP antagonists |
| 01/14/2014 | US8629136 Bisfluoroalkyl-1,4-benzodiazepinone compounds |
| 01/14/2014 | US8629135 Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer |
| 01/14/2014 | US8629134 Enantioselective synthesis of 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-jk][1]-benzazepin-2[1H]-one and zilpaterol |
| 01/14/2014 | US8629133 Dispiropyrrolidine derivatives |
| 01/14/2014 | US8629132 Kinase inhibitors |
| 01/14/2014 | US8629131 Enhanced erythropoiesis and iron metabolism |
| 01/14/2014 | US8629130 6-substituted estradiol derivatives and methods of use |
| 01/14/2014 | US8629129 Pharmaceutical compositions |
| 01/14/2014 | US8629128 Vitamin formulation |
| 01/14/2014 | US8629127 Compositions and methods of treatment for inflammatory diseases |
| 01/14/2014 | US8629126 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 01/14/2014 | US8629125 Inhibitors of fatty acid amide hydrolase |
| 01/14/2014 | US8629124 Dextran functionalized by hydrophobic amino acids |
| 01/14/2014 | US8629123 Use of dextran sulfate |
| 01/14/2014 | US8629121 High molecular weight polysaccharide that binds and inhibits virus |